Da 1 valutazioni negli ultimi 6 mesi. Non rappresenta una raccomandazione d'investimento.
Acquista
0%
Detenuti
100%
Vendi
0%
Info
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.